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Abstract: Vascular graft infection (VGI) is a rare but severe complication of vascular surgery that is
associated with a bad prognosis and high mortality rate. An accurate and prompt identification of the
infection and its extent is crucial for the correct management of the patient. However, standardized
diagnostic algorithms and a univocal consensus on the best strategy to reach a diagnosis still do not
exist. This review aims to summarize different radiological and Nuclear Medicine (NM) modalities
commonly adopted for the imaging of VGI. Moreover, we attempt to provide evidence-based answers
to several practical questions raised by clinicians and surgeons when they approach imaging in order
to plan the most appropriate radiological or NM examination for their patients.
Keywords: infection; vascular graft; multimodality imaging; WBC scintigraphy; FDG-PET/CT;
angio-CT; personalized medicine
1. Introduction
Vascular graft infection (VGI) is a rare condition, representing one of the most life-threatening
complications in vascular surgery. The incidence ranges from 1.5% to 6%, mainly depending on the
anatomic location of the graft, and clinical characteristics are highly variable and are related to the site
of the implant, causative pathogen, and time after surgery [1].
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Location categories for VGI include extracavitary (primarily in the groin—80%, or lower
extremities—20%) and intracavitary (primarily in the abdomen—70%, or less commonly within
the thorax—30%) sites. Extracavitary infections usually occur when there is a wound infection in
the groin or intraoperative contamination, while intracavitary infections are due to intraoperative
contamination, mechanical erosion in the bowel, genitourinary system or skin seeding by bacteremia,
or involvement in contiguous infectious processes such as spondylodiscitis.
According to the time of onset after surgery, VGIs may be classified in “early” infections if they
occur within 4 months after implantation and they usually show systemic signs and symptoms of
infection (as fever); or “late” infections when they occur after 4 months from surgery and, in this case,
signs and symptoms could be absent [2,3].
Patient related risk factors are diabetes, malnutrition, chronic renal impairment/failure, liver
disease/failure or cirrhosis, previous radiotherapy or chemotherapy, malignancy, autoimmune disorders,
long term corticosteroid use [4].
Diagnosis of VGI is complex, being related to clinical presentation, laboratory studies and imaging,
so quick and correct diagnosis of VGIs can be challenging.
Standard laboratory tests are usually non-specific: typical findings include leukocytosis (left shift)
and a high erythrocyte sedimentation rate. Cultures from wounds or perigraft fluid can be collected in
VGI-suspected patients in order to diagnose and guide antibiotic therapy [5].
The Management of Aortic Graft Infection Collaboration (MAGIC) depicted major and minor
criteria for VGI diagnosis, based on clinical/surgical, laboratory and radiological data: aortic graft
infection (AGI) can be suspected when there is one major criterion, or two minor criteria from two
different categories, whereas diagnosis is certain if there is one major criterion plus any other criterion
(both minor or major) from another category [6].
A prompt identification of the infection and its extent is crucial for prognostication of the patient
and for planning the correct treatment. Although there is general agreement that the diagnosis of VGI
derives from a combination of clinical, radiological, nuclear medicine (NM) and laboratory findings,
an univocal consensus on the diagnostic criteria for imaging modalities still does not exist.
This review aims to provide an updated overview of radiologic and NM strategies for the diagnosis
of VGI.
2. Surgical Management of VGI: How Can Imaging Be Helpful?
The management of VGI is extremely complex, and the centralization of the patient is crucial.
The treatment needs to be evaluated on a case-by-case basis. Antimicrobial therapy is an integral part
of VGI treatment. In the acute phase, intensive antimicrobial therapy with (broad range) antibiotics,
directed against the most likely infecting organisms, is indicated to control infection and sepsis [7].
However, when possible, surgical therapy must be attempted. Recently, the European Society for
Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and
Endograft Infections recommended the complete excision of all graft material and infected tissue for fit
patients (Class I, Level B) [7]. Historically, the gold standard surgical approach was the total removal
of the infected graft, extensive debridement of the infected area, and extra-anatomic reconstruction
(EAR) outside the infected field. However, this approach has higher 30-day mortality (26.7%) and
lowest one-year survival (54.3%) rates compared to in situ repair (ISR) [8]. Indeed, nowadays, most
surgeons prefer the second approach. Like the original gold standard, ISR includes complete removal
of the graft, aggressive debridement of the infected tissues, but, unlike EAR, ISR also provides arterial
reconstruction with suturing in the healthy, non-infected aorta (Figure 1). A video about graft removal
is available in supplementay materials (Video S1).
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Figure 1. (A,B) Pre-operative computed tomography (CT) scan showing graft disruption, perigraft 
fluid and air in a 72-year-old man with an infected abdominal endograft; (C) explanted graft after in 
situ repair (ISR) with visceral debranching: aorto-mesenteric bypass, right renal artery Y graft, 
aorto-left renal artery bypass. The reconstruction has been completed with lower extremity 
revascularization with extra-anatomic reconstruction (EAR) axillo-bifemoral; (D) final result after 
EAR 
Imaging plays a key role in confirming the diagnosis of VGI and guiding the treatment. In 
particular, it is useful in investigating the position and the structural integrity of the graft or 
endograft (Figure 1), it may confirm or exclude peri-graft inflammation, and delineate its extent; it 
may reveal the presence or absence of perigraft fluid or gas, anastomotic leakage or 
pseudoaneurysms, the grade of graft involvement and the presence of graft-enteric erosion/a fistula. 
Moreover, imaging is fundamental to plan a strategy for revascularization, and for imaging-guided 
perigraft fluid aspiration. 
3. Radiological Modalities for Imaging VGI 
3.1. Ultrasonography (US) 
Ultrasonography (US) is the first-choice imaging modality for assessing vascular diseases due 
to its well-known advantages, represented by repeatability, availability, cost-effectiveness, safety 
profile; moreover, it is non-invasive and easy to perform. However, it is operator dependent, and is 
hampered by patient habitus (obesity, intestinal gas or ascites) and the patient’s level of 
collaboration. In addition, it doesn’t offer a detailed anatomic roadmap like other imaging 
modalities. US can be useful in the evaluation of perigraft fluid collections or abscesses, and can 
distinguish a fluid collection from a hematoma or a pseudoaneurysm. It can also be used for 
US-guided aspiration [10]. Contrast-Enhanced Ultrasonography (CEUS) is not routinely used for the 
diagnosis of VGI, due to its unproven ability to improve diagnostic performance [11]. 
3.2. Computed Tomography (CT)—CT–Angiography (CTA) 
Computed tomography (CT) is the first-choice and gold-standard imaging modality, 
particularly in intracavitary VGI. A recent meta-analysis showed that CT–angiography (CTA) has an 
overall pooled sensitivity of 67% and an overall pooled specificity of 63% [12]. In particular, previous 
Figure 1. ( ,B) Pre-operative co puted to ography (CT) scan sho ing graft disruption, perigraft
fluid and air in a 72-year-old man with an infected abdominal endograft; (C) explanted graft after in situ
repair (ISR) with visceral debranching: aorto-mesenteric bypass, right renal artery Y graft, aorto-left
renal artery bypass. The reconstruction has been completed with lower extremity revascularization
with extra-anat mic reconstruction (EAR) axillo-bifemoral; (D) final result after EAR.
Different graft materials may be used for reconstruction, including autologous veins, cryopreserved
allografts, rifampicin-bonded or silver-coated synthetic grafts, and xenogenous graf s, and they seem
to show similar rates of i fection (veins 2%, cry preserved allografts 9%, rifampic n b nded o silve
coated prosthesis 1 %) [9].
Imaging plays a k y role in confirming the diagnosis of VGI and guiding the treatment. In
articul r, it is useful in investigating the position and the structural integrity of the graft or endograft
(Figure 1), it ay confirm or exclude peri-graft inflammation, and delineate its extent; t may reveal the
resence or absence of perigraft fluid or gas, anastomotic leakage or pseudoaneurysms, the grade of
graft involvement and the presence of graft-enteric erosion/a fistula. Moreover, imaging is fundamental
to plan a strategy for revascularizatio , and for imaging-guided perigraft fluid aspiration.
Radiological Modalities for Imaging VGI
3.1. Ultrasonography (US)
Ultrasonography (US) is the first-choice imaging modality for assessing vascular diseases due to
its well-known advantages, represented by repeatability, availability, cost-effectiveness, safety profile;
moreover, it is non-invasive and easy to perform. However, it is operator dependent, and is hampered
by patient habitus (obesity, intestinal gas or ascites) and the patient’s level of collaboration. In addition,
it doesn’t offer a detailed anatomic roadmap like other imaging modalities. US can be useful in the
evaluation of perigraft fluid collections or abscesses, and can distinguish a fluid collection from a
hematoma or a pseudoaneurysm. It can also be used for US-guided aspiration [10]. Contrast-Enhanced
Ultrasonography (CEUS) is not routinely used for the diagnosis of VGI, due to its unproven ability to
improve diagnostic performance [11].
3.2. Computed Tom graphy (CT)— –Angiography (CTA)
Computed tomography (CT) is the first-choice and gold-standard imaging modality, particularly
in intracavitary VGI. A recent meta-analysis showed that CT–angiography (CTA) has an overall pooled
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sensitivity of 67% and an overall pooled specificity of 63% [12]. In particular, previous studies depicted
a difference in the diagnostic performance of CTA between low- and high-grade VGI.
CT in low-grade infections has high false negative rates, resulting in a sensitivity of only 55.5% [6],
since it can be very difficult to differentiate early/low-grade VGI findings from para-physiological ones
(e.g., the postoperative local residues as small fluid collection or gas). It is not clearly defined at what
time after surgery the presence of gas or fluid can be considered to represent suspected/positive VGI
(Figure 2). On the other hand, CT has better accuracy in advanced or complex VGI (e.g., aorto-enteric
erosion/fistula), with a sensitivity and specificity of about 85–94% [6,12].
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Figure 2. Post-surgical ascending aortic repair (Bentall procedure) 1-month CT scan. From left panel to
right: unenhanced CT, arterial phase and late phase CT images show aortic graft patency with perigraft
fluid and stranding. These findings can be considered a typical post-operative appearance as confirmed
by their disappearance in the 3-month unenhanced CT image (right image).
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Pseudoaneurysm formation is a recognized finding in VGI, but it may also be present in a
non-infective setting, particularly following the focal dehiscence of a vascular suture. Septic emboli
from the infected graft can be a threatening occurrence, leading to vascular occlusions and the distal
spread of the infection [20].
VGI must not be confused with the primary vasculitis of large vessels, even though these
two entities are unlikely to be similar, the latter not usually being localized around the graft and
being associated with wall-thickening [21]. Chapman et al. reported the case of a VGI mimicking
hypertrophic osteoarthropathy [22]. Imaging alone, however, can be deceitful, due to the presence
of some diagnostic pitfall conditions (mostly iatrogenic) that can mimic VGI. In more detail, in
patients who underwent periaortic fluid aspiration or in patients with an aortic endograft and a
recent type-II endoleak embolization with the direct puncture of the aneurysmatic sac, gas-like images
could represent diagnostic pitfalls, mimicking graft infections. For these reasons, an adequate clinical
history knowledge, including all procedures performed, is mandatory to avoid false-positive diagnosis.
Performing nonenhanced imaging is particularly important in this postoperative setting, as surgical
or embolic devices (glue, coils, or other high-attenuation materials) may be most conspicuous at this
phase. Furthermore, some bioabsorbable hemostatic agents such as gelatin or cellulose may also
appear as an ill-defined, gas-filled heterogeneous mass, sometimes with rim enhancement, potentially
mimicking abscesses, hematomas, or retained foreign bodies (Figure 4). In selected cases, CT can be
also used to guide the percutaneous aspiration of perigraft fluid collections.
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Figure 4. In patients with aortic stent grafts who underwent embolization for type II endoleak,
diagnostic pitfalls need to be considered and known. They could be represented by hyperdense
structures/materials, represented by glue/liquid embolics or coils (A–C), or also by intra-sac gas, in the
case of percutaneous puncture/embolization, or new endografts with polymer-filled endobags (D–E).
3.3. Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) has not been evaluated as extensively as CT for the diagnosis of
VGI, but has demonstrated good positive and negative predictive values (95% and 80% respectively) [11].
MRI has some advantages compared to CT examination, due to the absence of radiation exposure, the
use of noniodinated contrast media, and the possible application of advanced imaging techniques (e.g.,
functional and dynamic imaging). However, t has some disadvant es like a longer examination time,
less availability, and higher costs. Moreover, a high magnet c field strength is required with an increase
in ferromagnetic artifacts due to metallic stents. Whe considering safety issues, it is well known that
risk of incompatibility is quite low, as MR-compatible materials have been increasingly used since the
mid-1990s. Most vascular grafts are mainly made of stainless steel or nitinol, are non-ferromagnetic, or
contain variable amounts of platinum, cobalt alloy, gold, tantalum, making them weakly ferromagnetic.
Furthermore, implantation against the vessel wall provides sufficient stability, reducing the risk of
dislodgement. Data from the literature allow us to conclude that MRI can be performed in patients after
vascular graft implantation without significant risk at any time, but the risk of incompatibility must be
well n and properly checked. Claustrophobia, pacemakers or patients not compliant with sedation
(<5%) are contraindications to MRI. it its high contrast resolution, can easily demonstrate
small perigraft fluid collections but, like CT, it is not able to distinguish the para-physiological perigraft
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fluid in the early postoperative period from an infected perigraft fluid collection. MRI imaging does
not allow for the differentiation of the signal void produced by calcifications of the aortic wall from
that of air bubbles in the perigraft infection [23]. In the case of graft infection, MRI can show eccentric
fluid collection with low to medium signal intensity on T1-weighted images and high signal intensity
on T2-weighted ones.
MRI is able to better distinguish perigraft fluid from inflammation and fibrosis than CT [18]. The
use of contrast-enhanced T1-weighted fat acquisitions may also help in detecting the surroundings of
tissue edema and inflammatory alteration that are indicative but non specific findings of infection.
3.4. Digital Subtraction Angiography (DSA)
DSA has a role for revascularization in selected patients (e.g., in case of distal limb or splanchnic
ischemia, occlusive disease or graft thrombosis), and to better define inflow and outflow targets for
the surgical bypass. It is mandatory for interventional procedures, whereas it has almost no use in
VGI diagnosis.
4. Nuclear Medicine Imaging of VGI
Functional hybrid imaging offers the possibility to study a process from a molecular point of
view and it is able to identify pathophysiological signs that can occur before morphological changes
become detectable.
Different radiopharmaceuticals and modalities are available for imaging infection and
inflammation. In particular, in suspected VGI, two procedures are currently applied, radiolabeled white
blood cells (WBC) scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed
tomography ([18F]FDG PET/CT).
4.1. Gamma-Camera Imaging for VGI
The role of radiolabeled WBC scintigraphy in the field of infection is nowadays well consolidated.
The possibility to specifically investigate granulocyte migration in tissues represents a surrogate marker
of infections [24]. It provides an accurate differentiation between infection and sterile inflammation.
This imaging modality is, therefore, considered the gold standard for the diagnosis of several infective
diseases [25].
Granulocytes can be easily radiolabeled with both 111In and 99mTc, with the latter being the
preferred isotope for both physical characteristics and dosimetric issues.
The European Society of Nuclear Medicine (EANM) provided several guidelines to address the
standardization of WBC labeling, acquisition protocols and interpretation criteria [25–27]. In particular,
for the assessment of VGI, a dynamic scan within the first 5 min is suggested in order to visualize the
vascular tree and aneurisms. Static images acquired, with times corrected for the isotope decay, at
30 min–1 h (early images) post injection (p.i.) and delayed images (2–4 h p.i.), might be sufficient to
provide the diagnosis. However, late images (20–24 h p.i.) are strongly recommended in equivocal
cases, low grade/chronic infection and follow-up studies [25,28] when positive single-photon emission
computed tomography (SPECT)/CT images are mandatory for the exact localization of the infection
(soft tissue only, graft, or both) and for the evaluation of its extent (7) (Figure 5), since their use has
been demonstrated as increasing the diagnostic accuracy [25,28].
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Figure 5. An example of 99mTc-labeled white blood cell ( BC) scintigraphy acquired with times
corrected for isotope decay at 30 in, 2 and 20 h p.i. in a patient with suspected abdo inal vascular
graft infection (VGI). Planar anterior i ages sho an increased uptake in abdo inal region that as
consistent for an infection (upper panel). Dingle-photon emission computed tomography (SPECT)/CT
images (botto ) acquired 2 h p.i. allowed the correct localization of the uptake in the inner of abdominal
aortic graft.
.i.
i ti li .
correctly acquired and displayed, the corr ct interpreta ion is derived from th comparison
of upt ke extent and int nsity between late and delayed images. By following these rec mme da ions,
we can asily differenti te between an infection from sterile inflam ation, which is n i fection
ch racterized by an increased uptake over time in terms of extent and/or intensity, and sterile
inflammatio characterized by a decreased or stable uptake ov r time [25,29,30].
fro the literature are inconsi tent, with differ nt accuracies being reported, dependi g on
the population sample and the different method an gold standard used. However, if we tak into
acc unt the few existing meta-analyses and ystematic reviews on this imag ng odality, the authors
ll conclude that radiol beled WBC is a powerful tool in diagnosing a VGI [12,31] (Table ).
particular, comparing 99mTc-WBC scintigraphy with 111In-WBC scintigraphy and CT, An ovazzi
et al. [31] reported higher sensitivity (97.7% vs. 84.1% vs. 75%), specificity (88.6% vs. 79.4% vs. 56.6%),
diagnostic accuracy (94.6% vs. 81.5% vs. 78.6), positive predictive alue (PPV) (90% vs. 85% vs.
100%) and negative predictive value (NPV) (100% vs. 93.8% vs. 82%) for the 99mTc-WBC scan. More
recently, in another met -analysis, WBC SPECT/CT demonstrate the highest iagnostic performance
in VGI diagnosis [12] (T ble 1). Indeed, th adde value of SPECT/CT over planar images has been
cle rly s own by several authors. In th study performed by Bar-Shalom and co-worke s, 111In-WBC
SPECT/CT was able to improve diagno is, b t er localize and evaluate the extent of the ise se in 67%
of patients with susp cted VGI [32]. These results were further confirmed in the retrospective study
perfo by Khaja and colleagues on 20 patients with suspecte VGI where the use of SPECT/CT
resulted in improved sensitivity, diagnostic accuracy and NPV compared to the planar images
standalone CT [33].
i il rl , in 55 patients with suspected late and low-grade VGI, 99mTc-WBC SPECT/CT showed a
specificity and sensitivity of 100%, far superior to planar images, SPECT tand alone and ultrasounds
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(US), reducing false positive results in 37% of patients [28]. The estimated sensitivity of WBCS (without
SPECT/CT) in diagnosing VGEI in the most recent meta-analysis was 0.90 (95% CI 0.85 to 0.94) with a
specificity of 0.88 (95% CI 0.81 to 0.94) [12]. When WBCS was combined with SPECT/CT, the sensitivity
increased to 0.99 (95% CI 0.92 to 1.00), with a specificity of 0.82 (95% CI 0.57 to 0.96) (Table 1).
Several factors, unfortunately, limit the routine use of radiolabeled WBC in clinical practice—the
labeling procedure is time consuming and it requires the manipulation of potentially infected blood.
For these reasons, the labeling procedure must be performed by trained personnel in dedicated
environments (with isolators, laboratories equipped with hoods and centrifuges). Moreover, multiple
timepoints are necessary for the acquisitions, thus requiring the patient to come back to the NM
Department the day after in order to conclude the exam. Because of the aforementioned limitations and
limited availability, the recent European Society for Vascular Surgery 2020 Clinical Practice Guidelines
on the Management of Vascular Graft and Endograft Infections does not recommended WBCs as the
first imaging modality in diagnosing VGI [7].
Scintigraphy with radiolabeled anti-granulocyte antibodies (AGA) has been investigated in
alternative WBC scintigraphy.
In VGI, some series reported a sensitivity of 92–100% and a specificity ranging from 62.5% to
100% [34–37]. The in vivo labeling procedure of a murine AGA is easier and quicker compared to the
in vitro labeling of WBC. However, the main drawback of this approach is related to the possibility
to induce human anti-murine antibodies (HAMA) after the administration of these molecules, thus
limiting their use in follow-up. Moreover, the data available in the literature on the use of radiolabeled
AGA in the assessment of VGI are based only on small series without standardized protocols of
acquisition and interpretation. Therefore, there is no convincing evidence supporting their superiority
over autologous leucocytes.
Table 1. Summary of the most relevant reviews and meta-analysis on Nuclear Medicine (NM) modalities
for imaging.
Paper Imaging Modality Sensitivity Specificity
Annovazzi 2005 [31]
99mTc-WBC
111In-WBC
CT
97.7%
84.1%
75%
88.6%
79.4%
56.6%
Reinders Folmer 2018 [12]
[18F]FDG PET
[18F]FDG PET/CT
WBC (planar)
WBC SPECT/CT
CTA
94% 70%
95% 80%
90% 88%
99% 82%
67% 63%
Khaja 2013 [33]
99mTc-WBC
111In-WBC
[18F]FDG PET/CT
83.7%
83%
93.7%
97.5%
87%
75%
Kim 2019 [38] [18F]FDG PET/CT 96% 74%
Rojoa 2019 [39]
[18F]FDG PET/CT:
1. graded uptake
2. focal uptake
3. SUVmax
4. T/B ratio
5. DTPI
89%
93%
98%
57%
100%
61%
78%
80%
76%
88%
White blood cell (WBC); computed tomography (CT); 18F-fluorodeoxyglucose positron emission tomography/computed
tomography ([18F]FDG PET/CT); single-photon emission computed tomography (SPECT); computed
tomography–angiography (CTA).
4.2. [18F]FDG PET/CT Imaging of VGI
In the last decades, [18F]FDG PET/CT has gained an important role in the field of infection and
inflammation, as summarized in the guidelines published in 2013 by EANM and the Society of Nuclear
Medicine and Molecular Imaging (SNMMI) [40].
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[18F]FDG PET/CT offers several advantages over labeled WBC: the presence of a CT co-registration
that does not require any change in the patient’s position and which allows a more precise localization
of the uptake and higher quality images than gamma camera isotopes. Moreover, the length of scan is
shorter (2–3 h vs. 20 h) and it provides a whole-body study without the need for blood manipulation.
Despite a high sensitivity, a major drawback of [18F]FDG is its relatively low specificity. False
positive results may be observed in post-surgical flogosis, especially within the first 6−8 weeks, and in
foreign-body reaction induced by the synthetic materials of the graft, characterized by a low-grade
inflammation [41,42]. Therefore, to limit the rate of false positive results, specific interpretation criteria
need to be applied.
Table 1 summarizes the results of the most recent meta-analyses evaluating [18F]FDG PET/CT in
the work-up of VGI [12,38,39]. The most recent one [38] reports a pooled sensitivity of 96%, ranging
between 81% [43] and 100% [42,44–46], and a pooled specificity of 74%, ranging between 29% [47] and
92% [48].
Several interpretation criteria for [18F]FDG PET/CT have been proposed and they mainly consider
the pattern of uptake, the tissue to background (T/B) ratio, the visual grading scale and the calculated
maximum standardized uptake value (SUVmax). The [18F]FDG pattern can be classified as “focal” or
“diffuse”, “homogeneous” or “inhomogeneous”, “mild” or “intense”.
Spacek et al., studying 96 low-grade prostheses, defined focal uptake as the most valid diagnostic
parameter, leading to a very high specificity (92.7%) and PPV (93.5%). Conversely, mild inhomogeneous
uptake must be interpreted with caution, being consistent with both low-grade infection and sterile
inflammation around the foreign body. The co-registered CT assessment for the definition of graft
borders (irregular vs. smooth) is also of paramount importance in this manuscript: the presence of
irregular borders associated to focal [18F] FDG uptake is highly predictive of VGI [41].
Focal uptake as major sign of VGI, compared to the diffuse homogeneous uptake found in up to
92% of non-infected grafts and most frequently observed in Dacron prostheses (Figure 6), has also
been reported by Keidar et al. [49].
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A four- or five-point visual scale was also proposed to diagnose VGI, with the presence of grades
3 or 4 being indicative of infection [50,51]. In grade 0, [18F]FDG uptake is similar to background
uptake; in grade 1, [18F]FDG uptake is similar to that which occurs in the inactive muscles and fat (low
[18F]FDG uptake); in grade 2, [18F]FDG uptake is higher than in inactive muscles (moderate [18F]FDG
uptake); in grade 3, [18F]FDG uptake is less than the physiologic uptake shown by the bladder (strong
[18F]FDG uptake) and in grade 4, [18F]FDG uptake is comparable to physiologic urinary uptake (very
strong [18F]FDG uptake).
The contributions of SUVmax and T/B ratio in the qualitative evaluation have also been examined.
Several thresholds of SUVmax have been proposed, but they are not universally recognized. Some
authors suggested a SUVmax > 8 in the perigraft area as cut-off value for distinguishing infected graft
from non-infected graft [42,50]. The use of this cut-off was associated with 100% of specificity and 80%
of sensitivity. However, since it is well known that SUVmax evaluation is affected by several technical
factors that may differ among the centers, T/B ratio is maybe a more reproducible parameter. Saleem
et al. proposed a cut-off of 5.9 ± 2.7 for infections (vs. 4.1 ± 2.1 in non-infected grafts) [50], but, of
course, these findings need to be further confirmed by larger studies and they need to be validated and
standardized. At the moment, SUV and TBR analyses seem to have limited value in the assessment
of VGI.
In a recently published meta-analysis exploring the accuracy and the efficacy of [18F]FDG PET/CT,
the authors analyzed five different methods of interpretation of a PET/CT scan [39]. The sensitivity and
specificity of qualitative assessment, using a five-point visual scale, were 89% and 61%, respectively;
for focal uptake, they were 93% and 78%, respectively; for SUVmax, they were 98% and 80%; 57% and
76% for T/B ratio, respectively, and 100% and 88% for dual timepoint imaging (DTPI). However, only
one paper investigated the added value of DTPI with additional delayed acquisitions and calculation
of percentages of SUVmax change between initial and delayed images [44]. Despite the limitations of
SUVmax, from this meta-analysis, it emerges that focal uptake and SUVmax are the most reliable tools
for the interpretation of a PET/CT scan. Nevertheless, larger prospective and retrospective studies are
needed to support these findings.
5. Consensus Statements from Round Table of 3rd European Congress of Infection
and Inflammation
During the 3rd European Congress of Infection and Inflammation organized in Rome in December
2019, several specialists evaluating patients with VGI gave lectures on this topic from different points
of view. Final discussions and a round table were carried out by the representatives of each specialty
(C.L., R.I., M.R., G.T., A.S., M.T., P.A.E., Y.T), who also contributed to the present review. Although
not officially endorsed by the respective European Societies of NM (EANM), Radiology (ESR) and
Vascular Surgery (ESVS), here we summarize several statements that emerged from the round table of
the Congress and that reached an oral consensus among these different specialists, aiming to provide
evidence-based answers to the most frequent clinical questions.
5.1. In Case of a Partial Resection Graft for a Fragile Patient Unfit for a Total VGI Explantation, the Exact
Infection Graft Location Could Be Useful for the Surgical Strategy. Which Radiological Integration Is More
Precise in This Diagnosis?
Once a WBC scintigraphy or a [18F]FDG PET/CT scan clearly demonstrates that infection is not
extended to the entire graft and perigraft tissues, a partial explanation is taken into consideration by
surgeons if invasiveness limitation is advisable. What the surgeons need to know is the graft patency,
the exact location of perigraft tissue alterations, the extent of fluid collection, and whether it would be
possible to perform ligations or surgical bypass. All of this information is easily and can currently be
obtained with CTA. There is almost no role for MRI. Only in selected cases could it be necessary to
resort to DSA and endovascular interventions like embolization or stent grafting before surgery.
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5.2. Does CTA Still Play a Role in Diagnosing Vascular Graft Infections or Should It Be Considered Obsolete,
Replaced by NM Imaging?
CTA is requested by clinicians as the first-choice imaging modality in cases of suspected VGI. The
main role is still to be considered for excluding this eventuality. A lack of significant peri-prosthetic
fluid collections or bubbles (and also other information) could be collected, such as structural graft
alterations, angulations or thrombosis. In these cases, a “wait and see” strategy can be adopted. In the
case of persistent symptoms and more founded suspicions, a second CTA is still indicated to ascertain
the evolution of the previous findings. In the case of endografts, CTA is the best imaging modality for
demonstrating ruptures, disconnections, displacements and endoleaks, which are conditions often
associated with infections. Last but not least, fluid collection aspiration for biological tests and cultures
is almost exclusively performed by interventional radiologists under CT guidance. Therefore, CTA still
plays a critical role in the diagnosis of VGI as the first diagnostic imaging modality [7]. NM modalities
are complementary and may be useful to map the extent of the infection. Therefore, for patients with a
clinical suspicion of vascular graft/endograft infection and with non-convincing findings on CTA, the
use of WBC scintigraphy or [18F]FDG PET/CT is recommended as an additional imaging modality to
improve diagnostic accuracy.
5.3. Does Antibiotic Therapy Affect NM Exams Accuracy? Should Antibiotic Therapy Be Stopped before NM
Exams? If Yes, How Long before?
The influence of ongoing antimicrobial treatment on the different NM modalities and, in particular,
on radiolabeled WBC scintigraphy, is still a matter of debate. Although the use of antibiotics is
frequently reported in several papers, the duration of treatment is not always mentioned and it is not
linked to the outcome of WBC scintigraphy or [18F]FDG PET/CT. Moreover, data regarding VGI do not
exist, therefore a definitive conclusion on this topic cannot be provided.
From other clinical contexts mainly focused on musculoskeletal infections, some authors suggested
that antibiotic treatment does not affect the accuracy of radiolabeled WBC; however, it is well known that
antimicrobial treatment may reduce the chemiotaxis of leukocytes, thus resulting in lower migration
into infected sites. Therefore, when antimicrobial therapy is ongoing, it should be considered during the
scan interpretation, whereas, if the patient is at the end of antibiotic treatment, it is a common practice
in the NM department to delay the execution of WBC scintigraphy after 2 weeks of therapy withdrawal.
Although antimicrobial treatment is known to decrease the intensity of [18F]FDG uptake, in a
recently published retrospective study aiming to assess whether [18F]FDG PET/CT performance for the
diagnosis of infective processes could be affected by ongoing antibiotic therapy, no false negative cases
were detected in the group of patients receiving the treatment, thus demonstrating that the accuracy of
this modality is not influenced by antibiotic administration [52].
5.4. Is It Reasonable to Perform an [18F]FDG-PET/CT after a Positive WBC Scintigraphy?
The answer to this question may be extracted in the meta-analysis of Reinders Folmer, where
pre and post-test probabilities of having VGI have been calculated for CTA, [18F]FDG PET, [18F]FDG
PET/CT, WBC scintigraphy with only planar images and WBC scintigraphy with planar images +
SPECT/CT [12]. Of these modalities, WBC scintigraphy combined with SPECT/CT acquisitions scored
best in terms of positive post-test probability (96%), followed by WBC scintigraphy with only planar
images (94%), [18F]FDG PET/CT (83%), CTA (80%) and standalone [18F]FDG PET (78%). It means
that, after positive WBC scintigraphy + SPECT/CT, a patient suspected of having a VGI has a 96%
probability of being infected. This is not surprising considering the high number of true positives
detected by this modality, which is, of course, superior to the number of true positives identified by
[18F]FDG PET/CT.
Therefore, we can assume that a positive WBC scintigraphy, especially if correctly acquired with
SPECT/CT and interpreted by following EANM recommendations, is sufficient for the diagnosis and
does not require an additional study with [18F]FDG PET/CT.
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5.5. Which Imaging Modality Is Recommended Within the First 3 Months after Surgery in the Suspicion of
Early Infection?
It is well known that inflammatory changes, such as non-infected hematoma or lymphocele,
may occur and persist for months after surgery, especially in more invasive approaches, and may
result in false positive cases at both [18F]FDG PET/CT scans and, more rarely, at WBC scintigraphy,
thus impacting on their accuracy. Moreover, synthetic graft material (Dacron or Gore-Tex) induces a
foreign-body reaction which may present [18F]FDG uptake, thus representing a frequent pitfall in the
interpretation of a PET scan. Indeed, after surgery, some inflammatory cells, mainly macrophages and
fibroblasts, may use glucose as a source of energy for completing the healing process; for this reason,
[18F]FDG is taken up by the healing tissue.
In a large retrospective study performed by Keidar, as previously mentioned, the authors explored
the [18F]FDG uptake in 107 non-infected grafts in relation to graft material and time elapsed from
surgery for a follow-up of up to 16 years. In this wide interval of time, they found no substantial
reduction in the metabolic activity shown by synthetic grafts, thus meaning that post-surgical flogosis
could be detectable after many years following surgery [49]. However, the pattern could be helpful in
differentiating a sterile inflammation from an infection, since diffuse homogeneous uptake is usually
observed in the first condition, reflecting a low-grade inflammation. On the contrary, infections usually
show focal uptake. These findings were also confirmed by Wassèlius and colleagues in 10 out of
12 grafts implanted in open surgery and one out of four patients who underwent an endovascular
procedure (mean time interval from surgery: 5.8 years). Notably, only one of the 16 patients had an
infection based on biochemical and clinical data [46].
In terms of the usefulness of radiolabeled WBC in the post-surgical period, it is well known that
this modality has higher specificity and accuracy in differentiating a sterile flogosis from an infection,
compared with [18F]FDG PET/CT. In 2006, Liberatore et al. found no false positive results in patients
studied within 1 month after surgery, concluding that this modality is reliable to assess an infection in
the earlier stages after endovascular surgery [53]. Of course, this conclusion could be affected by the
type of population studied and, in particular, by the probability of having an infection or not, and
larger studies are needed to confirm this finding.
In conclusion, we can state that the perfect timing to perform an NM examination mainly depends
on the type of surgery (open vs. endovascular approach), clinical indication and pre-test probability
of infection. After surgery, the presence of aseptic flogosis must always be taken into consideration,
especially in the interpretation of an [18F]FDG PET/CT scan and, therefore, the evaluation of the pattern
of uptake and CT abnormalities must be accurate in order to correctly interpret the exam.
Larger multicenter studies are needed in order to provide an evidence-based answer to
this question.
6. Conclusions
Accurate diagnosis of VGI is challenging and requires a multimodality and multidisciplinary
approach in order to ensure the best management of these patients. Several radiological and NM
modalities are available, each one with its pros and cons. US is usually used for extracavitary graft
infection, while CT/CTA is the first-choice imaging modality for intracavitary graft infection. However,
CTA may present some limitations, particularly in low-grade infections. In cases of equivocal CTA,
WBC scintigraphy or [18F]FDG PET/CT are recommended in order to improve diagnostic accuracy, but
the use of appropriate interpretation criteria is mandatory.
The best diagnostic option would be to combine anatomical/radiological and functional imaging
in order to obtain an earlier and more effective diagnosis, which should be mandatory for decision
making and for defining the best treatment options.
Many efforts still need to be directed towards the definition of accurate algorithms that aim to
make diagnostic approaches more uniform among different centers.
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